Lexicon Pharmaceuticals, Inc.LXRXNASDAQ
Loading
Operating Expenses Over TimeContracting
Percentile Rank21
3Y CAGR+26.7%
5Y CAGR+7.1%
Year-over-Year Change
Expenses from normal business operations (SG&A, R&D, etc.)
3Y CAGR
+26.7%/yr
vs -26.3%/yr prior
5Y CAGR
+7.1%/yr
Recent acceleration
Acceleration
+53.0pp
Accelerating
Percentile
P21
Within normal range
vs 5Y Ago
1.4x
Solid growth
Streak
1 yr
Consecutive declineContracting
| Period | Value | YoY Change |
|---|---|---|
| 2025 | $98.44M | -56.7% |
| 2024 | $227.58M | +99.7% |
| 2023 | $113.98M | +135.6% |
| 2022 | $48.38M | +49.6% |
| 2021 | $32.34M | -53.7% |
| 2020 | $69.87M | -60.6% |
| 2019 | $177.40M | +8.2% |
| 2018 | $164.00M | -26.5% |
| 2017 | $223.02M | +0.8% |
| 2016 | $221.19M | - |